NuCana
NCNA
#10506
Rank
A$12.88 M
Marketcap
A$3.10
Share price
3.24%
Change (1 day)
-74.49%
Change (1 year)

Earnings for NuCana (NCNA)

Earnings in 2025 (TTM): -A$39.88 Million

According to NuCana 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$41.08 Million, an increase over its 2023 earnings that were of -A$54.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NuCana from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$39.88 Million-2.93%
2024 -A$41.08 Million-24.16%
2023 -A$54.16 Million-27.12%
2022 -A$74.32 Million-13.88%
2021 -A$86.3 Million45.6%
2020 -A$59.27 Million29.44%
2019 -A$45.79 Million12.74%
2018 -A$40.62 Million-8.89%
2017 -A$44.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.2 Billion 450.75%๐Ÿ‡บ๐Ÿ‡ธ USA